Anthracimycin
CAS: 1452849-94-3
Ref. 3D-CIC84994
| 1mg | Descontinuado | ||
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado |
Informação sobre produto
Nome:
Anthracimycin
Sinónimos:
- (4R,7R,8E,10Z,12S,12aR,14aR,18aS,18bR)-7,12,12a,14a,15,18,18a,18b-Octahydro-4,7,12,16-tetramethyl-1H-naphth[1,2-g]oxacyclotetradecin-1,3,5(2H,4H)-dione
- N1097
- 1H-Naphth[1,2-g]oxacyclotetradecin-1,3,5(2H,4H)-dione, 7,12,12a,14a,15,18,18a,18b-octahydro-4,7,12,16-tetramethyl-, (4R,7R,8E,10Z,12S,12aR,14aR,18aS,18bR)-
Descrição:
Anthracimycin is a potent anticancer agent that is derived from a marine bacterium. It targets the cell cycle of human tumor cells and induces apoptosis, which leads to cell death. Anthracimycin acts as an inhibitor of protein kinases, which are enzymes involved in many cellular processes including cell division and growth. This medicinal compound has been found to be effective against various types of cancer including breast, colon, and lung cancer. Chinese researchers have identified an analog of anthracimycin in human urine that may have potential as a novel cancer therapeutic agent. This inhibitor has shown promising results in preclinical studies and is currently being evaluated for its efficacy in clinical trials.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
396.5 g/mol
Fórmula:
C25H32O4
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
